Bispecific Antibody Therapy With Elranatamab for Refractory Waldenström Macroglobulinemia: A Case Report

Clinical Lymphoma, Myeloma and Leukemia · Published 2026-05-01 · DOI 10.1016/j.clml.2026.04.023

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.clml.2026.04.023

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles